Study in Hepatitis C Virus (HCV) Infected Patients Undergoing Liver Transplantation to Evaluate a Human Monoclonal Antibody Against Hepatitis C

PHASE2TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
HCV InfectionLiver Transplantation
Interventions
BIOLOGICAL

MBL-HCV1

50 mg/kg MBL-HCV1, intravenous

OTHER

0.9% Sodium chloride Placebo

0.9% sodium chloride, intravenous

Trial Locations (8)

10029

Mount Sinai Hospital, New York

38104

Methodist Healthcare Foundation, Memphis

44195

Cleveland Clinic Foundation, Cleveland

48202

Henry Ford Health System, Detroit

06504

Yale-New Haven Hospital, New Haven

02114

Massachusetts General Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

01805

Lahey Clinic, Burlington

Sponsors

Lead Sponsor

All Listed Sponsors
lead

MassBiologics

OTHER